Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2009 - 2026)

Bausch Health Companies has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $24.5 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $24.5 billion, down 7.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $105.0 billion (down 0.97% YoY), and the FY2025 annual result was $26.4 billion, down 0.59% from the prior year.
• Liabilities and Shareholders Equity came in at $24.5 billion for Q1 2026 at Bausch Health Companies, down from $26.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $29.1 billion in Q1 2022 to a low of $24.5 billion in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $26.5 billion (2024), against an average of $26.6 billion.
• Peak annual rise in Liabilities and Shareholders Equity reached 6.48% in 2023, while the deepest fall reached 12.53% in 2023.
• Bausch Health Companies' Liabilities and Shareholders Equity stood at $25.7 billion in 2022, then climbed by 6.48% to $27.4 billion in 2023, then slipped by 3.02% to $26.5 billion in 2024, then retreated by 0.59% to $26.4 billion in 2025, then declined by 7.08% to $24.5 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $24.5 billion (Q1 2026), $26.4 billion (Q4 2025), and $26.8 billion (Q3 2025), per Business Quant data.